Comparison Chart Ryvu Therapeutics S.A.

Equities

Delayed Warsaw S.E. Other stock markets 09:08:21 2024-05-17 am EDT			5-day change	1st Jan Change
54.6 ^PLN	-0.73%		+7.69%	-5.04%

Mar. 13	Ryvu Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 06	Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	RYVU THERAPEUTICS S.A.	Bio Therapeutic Drugs	-0.73%	+7.69%	-5.04%	-7.46%	-9.00%	325M